Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00834054
Other study ID # 2008/18
Secondary ID
Status Completed
Phase N/A
First received February 2, 2009
Last updated September 22, 2016
Start date January 2009
Est. completion date July 2011

Study information

Verified date September 2016
Source Hopital Foch
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Observational

Clinical Trial Summary

Repeated measurements of lung water by single transpulmonary thermodilution during the first postoperative days following lung transplantation


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date July 2011
Est. primary completion date July 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- double-lung transplanted patients

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
Double-lung transplantation
Double-lung transplanted patients

Locations

Country Name City State
France Hopital Foch Suresnes

Sponsors (1)

Lead Sponsor Collaborator
Hopital Foch

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary extra-vascular lung water first postoperative days No
Secondary pulmonary permeability index first postoperative days No
See also
  Status Clinical Trial Phase
Terminated NCT00391703 - Assessment of Quadriceps Muscle Electrostimulation Used in Patients Suffering From Cystic Fibrosis N/A
Completed NCT04225962 - Intimacy of Women With Cystic Fibrosis
Terminated NCT00356629 - Development of a Noninvasive Method of Evaluation of Pulmonary Inflammation in the Condensates of Exhaled Air N/A
Not yet recruiting NCT04625829 - Anthropological Survey on the Use of Essential Oils (EOs) by Cystic Fibrosis Patients: a Quantitative and Qualitative Approach
Completed NCT03653377 - Human Papilloma Virus Vaccination in Girls With Cystic Fibrosis (VACCIN-HPV-MUC2)